Page last updated: 2024-12-08

ambroxol-theophylline-7-acetate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID176595
CHEMBL ID4297663
SCHEMBL ID1650322
MeSH IDM0207191

Synonyms (31)

Synonym
acebrophylline
96989-76-3
ambroxol-theophylline-7-acetate
ambromucil
surfolase
unii-0hm1e174tn
ambroxol acefyllinate
0hm1e174tn ,
ambroxol theophyllinacetate
broncomnes
cyclohexanol, 4-(((2-amino-3,5-dibromophenyl)methyl)amino)-, trans-, mono(1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-7h-purine-7-acetate) (salt)
AKOS015899892
ambroxol acefyllinate [who-dd]
ambroxol acefyllinate [mart.]
ambroxol theophyllinate
ambroxol theophyllinate [who-dd]
SCHEMBL1650322
IPUHJDQWESJTGD-UHFFFAOYSA-N
2-(1,3-dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1h-purin-7-yl)acetic acid; 4-[(2-amino-3,5-dibromophenyl)(methyl)amino]cyclohexan-1-ol
4-((2-amino-3,5-dibromobenzyl)amino)cyclohexan-1-ol 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7h-purin-7-yl)acetic acid
4-[(2-amino-3,5-dibromophenyl)methylamino]cyclohexan-1-ol;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetic acid
179118-73-1
DB13141
DTXSID60914235
(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7h-purin-7-yl)acetic acid--4-{[(2-amino-3,5-dibromophenyl)methyl]amino}cyclohexan-1-ol (1/1)
Q19607226
ambromucil pound>>ambroxol-theophylline-7-acetate
BCP28655
CHEMBL4297663
GLXC-26022
PD053871
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.60

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.60 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.55 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.60)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (16.67%)6.00%
Case Studies1 (16.67%)4.05%
Observational0 (0.00%)0.25%
Other4 (66.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]